Evolent Health Inc. has announced the launch of a proposed public offering of $175 million of its class A common shares registered under a shelf statement.
The company expects to grant the underwriters a 30-day option to purchase an additional $26.3 million of its class A common shares. All shares will be offered by the company.
Evolent Health plans to transfer the net proceeds from this offering to its subsidiary, Evolent Health LLC, which is expected to use the net proceeds for working capital and other general corporate purposes, including to expand its business through acquisitions and investments.
J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC are acting as joint book-running managers and as representatives of the underwriters for the offering. Wells Fargo Securities LLC, William Blair & Co. LLC and SunTrust Robinson Humphrey Inc. are acting as lead managers, while Leerink Partners LLC and Robert W. Baird & Co. Inc. are acting as co-managers.